Vancouver, British Columbia, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The global clinical biomarkers market is expected to reach a market size of USD 38.79 billion at a steady CAGR of 10.2% in 2027, according to latest analysis by Emergen Research. This steady revenue growth of the market can be attributed to increasing prevalence of obesity and diabetes among the growing population. Increasing prevalence of chronic diseases globally due to sedentary lifestyle, unhealthy diet, rising tobacco use, exposure to secondhand smoke, lack of physical activity, and excessive alcohol are some key factors driving growth of the clinical biomarkers market, and the trend is expected to continue during the forecast period.
Increasing research and development activities for technological advancements of clinical biomarkers is expected to offer growth opportunities for major players in the market in future. Increasing prevalence of neurological disorders among the growing geriatric population globally is contributing significantly to rising utilization of clinical biomarkers for neurological disease treatment. Moreover, increasing government initiatives to minimize the healthcare burden and rising focus on early detection of diseases are factors expected to support growth of the clinical biomarkers market going ahead.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/23
Top Companies Profiled in Veterinary Vaccines Market Report are:
Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Siemens Healthcare Private Limited, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Qiagen, Abbott Laboratories, Epigenomics AG, and Meso Scale Diagnostics LLC.
Key Highlights in The Report
- In September 2020, Siemens Healthineers announced a collaboration with Novartis Pharma AG for development, designing, and commercialization of diagnostic tests for therapeutic products across the therapeutic pipeline of Novartis. The collaboration is expected to support the development of serum Neurofilament Light Chain (sNFL) immunoassay in order to support the MS and other neuroscience programs of Novartis. The neurofilament light chain (NFL) is a highly specific biomarker for nerve cell injury measured in cerebral spinal fluid and blood.
- Safety biomarkers segment accounted for largest revenue share of 41.8% in 2019. Increasing adoption of safety biomarkers in drug research and production field is expected to continue to drive revenue growth of the safety biomarkers segment in the clinical biomarkers market during the forecast period.
- Cancer disease segment accounted for largest revenue share of 37.6% in 2019. Increasing demand for reliable and fast diagnostic instruments and a steep rise in global prevalence of cancer are key factors driving usage of clinical biomarkers in cancer treatment.
- Personalized medicines segment accounted for a significantly high revenue share in the clinical biomarkers market in 2019. Increasing consumer awareness regarding the benefits of personalized medicines has been driving demand for personalized medicines, and the trend is expected to continue during the forecast period.
- Revenue from the market in Asia Pacific is expected to expand at a rapid rate during the forecast period. Increasing government initiatives in various countries in the region to minimize healthcare burden and increasing investment by leading biomarker companies for advancements in clinical biomarkers are factors expected to drive growth of the clinical biomarkers market in the region.
- Key players in the market include Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Siemens Healthcare Private Limited, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Qiagen, Abbott Laboratories, Epigenomics AG, and Meso Scale Diagnostics LLC.
Check Our Prices@ https://www.emergenresearch.com/select-license/23
For the purpose of this report, Emergen Research has segmented the global clinical biomarkers market on the basis of type, disease, application, and region:
- Type Outlook (Revenue, USD Billion; 2017–2027)
- Safety
- Efficacy
- Validation
- Disease Outlook (Revenue, USD Billion; 2017–2027)
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others
- Application Outlook (Revenue, USD Billion; 2017–2027)
- Diagnostics
- Drug Discovery & Development
- Personalized Medicines
- Others
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/clinical-biomarkers-market
- Regional Outlook (Revenue, USD Billion; 2017–2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
- North America
Take a Look at our Related Reports:
Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions
Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region
Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region
Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027
Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-clinical-biomarkers-market